Products for Research Use Only
RegisterLogin

αGalCer-RBD

CAT: 0013-GTR19221329-01Size: 5 mgDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0013-GTR19221329-01Size:5 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
αGalCer-RBD is a self-adjuvanting vaccine candidate that conjugates the iNKT cell agonist α-Galactosylceramide to the SARS-CoV-2 RBD domain. It induces robust immunity by generating RBD-specific, cytokine-producing T cells, as demonstrated in preclinical in vivo studies against SARS-CoV-2 and its variants.
Field of Research
Infectious Disease & Virology
Molecular Formula
C60H118N4O14
Molecular Weight
1119.6
Storage Conditions
-20°C
Notes
For research use only.

Related Products

CatalogName
GTR19192116α-GalCer analog 8
GTR19268690-01C6 (6-Azido) GalCer
GTR19219484-01PLpro/RBD-IN-1
GTR19009444-01Spike RBD, rec
GTR18703899-01Spike RBD Antibody
GTR18291866-01Anti-RBD (SARS-CoV-2) antibody – clone RBD.01
GTR18696662-01RBD Human Monoclonal Antibody
GTR18696661-01RBD Human Monoclonal Antibody
GTR18696660-01RBD Human Monoclonal Antibody
GTR18777493-01PDCoV Spike RBD Antibody

Alternative Products

CatalogName
HY-144120αGalCer-RBD
900135Galactosylceramide (GalCer)
900135KHGalactosylceramide (GalCer) KLH
HY-172001α-GalCer analog 8
900135BAGalactosylceramide (GalCer) BSA
TYD-04417-01C6 (6-Azido) GalCer
G1042-01A-Galactosyl-C16-ceramide (GalCer)
770019Galactosylceramide (GalCer) ELISA Kit
MBS5796798alpha-GalCer analog 8
LVP1686TCR- (CD1d-α-GalCer) (Clone NKT15) (No Marker)

Popular Products